Twin-to-twin transfusion syndrome: an antiangiogenic state?
about
Discordant placental echogenicity: a novel sign of impaired placental perfusion in twin-twin transfusion syndrome?Pre-eclampsia part 1: current understanding of its pathophysiology.Monochorionic twin pregnancy: screening, pathogenesis of complications and management in the era of microinvasive fetal surgery.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluidAn imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.What-and why-the pathologist should know about twin-to-twin transfusion syndrome.Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study.The impact of laser surgery on angiogenic and anti-angiogenic factors in twin-twin transfusion syndrome: a prospective study.Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Prenatal management and outcomes in mirror syndrome associated with twin-twin transfusion syndrome.The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?The Placenta in Twin-to-Twin Transfusion Syndrome and Twin Anemia Polycythemia Sequence.Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.Maternal cell-free messenger RNA in twin pregnancies: the effects of chorionicity and severe twin to twin transfusion syndrome (TTTS).
P2860
Q30525061-F451486B-DD0C-4B0A-9D61-9AD6B10CEB33Q33416340-8AD3EFE0-0C86-4DD6-8951-B979467B87B7Q33632509-B4C5B60D-373F-4956-8193-326D343FA3B9Q33863973-60E6B779-6937-4AA1-99A1-2FA31A448BE0Q34119241-7B0A011B-6059-430E-BAF2-4A0572BDFFCFQ34151967-D58B5223-FCE9-4FFF-B0E9-0A1E4B038744Q34470845-88113C09-10CC-4FD8-B054-DA808D68CB1FQ34505090-A535A0FD-B277-415A-8D37-47CCCDAB7F17Q34619975-A952F34A-4FC9-4274-9DA1-28E016DED7CDQ34687277-10BD05EC-9AE7-4F65-AB28-1597DDBF9524Q35015402-60386706-13B0-4060-BB42-36102C492C2CQ36062460-E5CC5057-9F98-480B-9141-797C96C40824Q36189578-4F5A7A34-32A9-4F69-85E5-341E0F405BF2Q36221487-71A8D2CC-74B9-4982-BC29-4D5531F0702BQ36315177-1F036D39-C74E-47E9-89AC-611C0D5862D4Q37612429-6BC8333A-47FC-492E-871A-7E726FD129B3Q37935034-5DC2C535-534E-4BF5-8211-CA075205DCDEQ38436237-085CF9ED-EB7B-4916-B69D-F2EAE727BB34Q38458497-7094BFB6-563A-4C80-8844-9CED386C65A5Q41033848-2B866A80-B7DF-4D20-8425-AB212824B7E9Q46315751-038C5A02-A01F-4F9E-8914-BD5D5D10D1F9Q47645647-CAF897B8-804E-496D-A4D3-F3D7C890D4F0Q49243157-0B4A646F-A545-4829-B91F-CB12A3D569B8Q53118249-BFC5CCFA-24F4-407F-B227-35C3ECB81A51Q54406971-2ED5886A-C8AC-4D24-B266-087A1E6D94C6Q54492924-F6C79FD9-DFE7-4A56-B8AF-CB2B71FD8348
P2860
Twin-to-twin transfusion syndrome: an antiangiogenic state?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@en
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@nl
type
label
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@en
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@nl
prefLabel
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@en
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@nl
P2093
P2860
P1476
Twin-to-twin transfusion syndrome: an antiangiogenic state?
@en
P2093
Chong Jai Kim
Eleazar Soto
Francesca Gotsch
Jimmy Espinoza
Juan Pedro Kusanovic
Jyh Kae Nien
Nandor G Than
Natalia Camacho
Offer Erez
Pooja Mittal
P2860
P304
P356
10.1016/J.AJOG.2008.02.016
P407
P577
2008-04-01T00:00:00Z